-- Signature Resources (SGU.V) 周一收盘后公布了金刚石钻孔 (DDH) LM 25-03 的钻探结果。该钻孔是其冬季钻探计划的一部分,位于辉绿岩脉以东,旨在测试凌曼湖矿床的深度延伸情况。 该公司表示,钻探发现了所有三个已知矿化带(南矿化带、中矿化带和北矿化带)的向下延伸部分,这支持了地质模型。 该公司称:“南矿化带是最窄的截距,从钻探深度 298 米到 302 米,厚度为 4 米,平均金品位为 0.36 克/吨,其中包括一段 1 米厚的截距,金品位为 1.11 克/吨。” “中央矿带最宽处为34米,平均金品位为0.33克/吨,其中包括一段1米厚的矿段,金品位高达7.37克/吨。北矿带在498米处被截获,并继续延伸22米,平均金品位为0.57克/吨。北矿带内有一段5米厚的矿段,平均金品位为2.21克/吨。” 该公司补充说,LM 25-03井已“成功”将北矿带的深度延伸了249米。 该公司还表示,已完成六个双井钻探(DDH),第七个双井钻探已完成47%。截至目前,已完成钻探3246米。 Signature公司进一步补充道,DDH LM 25-04和LM 25-05的样品已制备完成并送至SGS伯纳比实验室,目前正在等待化验结果,预计将在未来30天内获得结果。该公司还表示,剩余的钻探工作将很快完成,所有剩余的岩芯样品都将进行处理并送往SGS伯纳比实验室进行化验。
Related Articles
Morgan Stanley Downgrades AES to Equalweight From Overweight, Adjusts Price Target to $15 From $23
AES (AES) has an average rating of hold and mean price target of $15.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Compass Therapeutics Tovecimig Study Falls Short on Overall Survival Endpoint in Biliary Tract Cancer; Shares Fall Pre-Bell
Compass Therapeutics (CMPX) reported that its experimental drug tovecimig did not meet the overall survival secondary endpoint in a phase 2/3 study in patients with advanced biliary tract cancer, the company said Monday.Shares of the company fell more than 63% in recent pre-bell activity Monday.The company said that tovecimig plus paclitaxel did not show a statistically significant overall survival benefit versus chemotherapy alone, largely due to high crossover from the control arm and prolonged survival after switching to the drug.However, the study met other key endpoints, including statistically significant improvements in progression-free survival and overall response rate versus paclitaxel alone.Compass Therapeutics plans to meet with the US Food and Drug Administration to discuss the results ahead of a planned biologics license application submission, it added.Price: $1.91, Change: $-3.11, Percent Change: -63.35%
Gold Eases Early Even as the Dollar Falls Ahead of This Week's U.S. Interest Rate Decision
Gold prices eased early on Monday, remaining rangebound even as the dollar fell ahead of the Wednesday interest-rate announcement from the Federal Reserve.Gold for June delivery was last seen down US$26.50 to US$4,714.40 per ounce, remaining within the US$200 range it has been stuck in since the start of the war on Iran, as high oil prices raise concerns over higher inflation and threaten to boost interest rates.The Federal Open Market Committee (FOMC) will make its latest interest-rate decision at the Wednesday afternoon end to its two-day meeting. The CME FedWatch Tool sees a 100% probability the group will leave rates unchanged."Gold remains stuck in neutral within a broad USD 200 range around USD 4,750, with most intraday price action dictated by energy prices and the ebb and flow of headlines from the White House and the Middle East. The FOMC is widely expected to leave rates unchanged on Wednesday," Saxo Bank noted.The dollar was lower early, with the ICE dollar index last seen down 0.28 points to 98.26. Treasury yields rose, with the yield on the two-year note up 1.0 basis points to 3.801%, while the 10-year note was paying 4.321%, up 1.3 points.